HomeRKV • CVE
add
Rakovina Therapeutics Inc
Previous close
$0.095
Day range
$0.10 - $0.11
Year range
$0.090 - $2.30
Market cap
2.01M CAD
Avg Volume
38.70K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
In the news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.64M | 74.05% |
Net income | -1.78M | -76.21% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.51M | -86.44% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 822.29K | 222.41% |
Total assets | 5.27M | -0.76% |
Total liabilities | 3.38M | 51.32% |
Total equity | 1.89M | — |
Shares outstanding | 21.15M | — |
Price to book | 1.06 | — |
Return on assets | -69.43% | — |
Return on capital | -80.23% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.78M | -76.21% |
Cash from operations | -1.04M | 25.87% |
Cash from investing | — | — |
Cash from financing | -25.39K | -109.57% |
Net change in cash | -1.06M | 6.25% |
Free cash flow | -571.81K | 44.75% |
About
Founded
2019
Headquarters
Website
